CoreCap Advisors’s ResMed RMD Stock Holding History

CoreCap Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.55K	Buy	7 +6	+600%	+$1.31K	﹤0.01%	2573
2026 Q2	$195	Sell	1 -7	-88%	-$1.45K	﹤0.01%	3009
2026 Q1	$1.8K	Buy	8 +5	+167%	+$1.25K	﹤0.01%	2437
2025 Q4	$723	Sell	3 -9	-75%	-$2.3K	﹤0.01%	2651
2025 Q3	$3.28K	Buy	12 +6	+100%	+$1.64K	﹤0.01%	2278
2025 Q2	$1.55K	Sell	6 -16	-73%	-$3.82K	﹤0.01%	2359
2025 Q1	$4.92K	Buy	22 +21	+2,100%	+$4.9K	﹤0.01%	2096
2024 Q4	$229	Sell	1 -35	-97%	-$8.43K	﹤0.01%	2712
2024 Q3	$8.79K	Buy	+36	New	+$8.04K	﹤0.01%	1827
2024 Q2	–	Sell	-36	Closed	-$7.13K	–	2372
2024 Q1	$7.13K	Buy	+36	New	+$6.6K	﹤0.01%	1830
2022 Q4	$7.28K	Buy	+35	New	+$7.69K	﹤0.01%	1643
2022 Q3	–	Sell	-35	Closed	-$7K	–	1748
2022 Q2	$7K	Buy	+35	New	+$7.45K	﹤0.01%	1578
2022 Q1	–	Sell	-35	Closed	-$9K	–	1743
2021 Q4	$9K	Buy	+35	New	+$9.08K	﹤0.01%	1589

Other funds holding RMD

Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return

Washington Trust Advisors Wellesley, Massachusetts $1.4B AUM 26.88% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Fideuram - Intesa Sanpaolo Private Banking Turin $3.5B AUM 45.13% 1-Year Est. Return

NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return

Addenda Capital Montreal, Quebec, Canada $3.78B AUM 23.53% 1-Year Est. Return

CoreCap Advisors's RMD Position: Q3 2026 in Review

CoreCap Advisors increased its ResMed (RMD) stake by 600% in Q3 2026, buying an estimated $1.31K and bringing the position to 7 shares worth $1.55K. The position accounts for ﹤0.01% of the portfolio, ranked #2573.

CoreCap Advisors first reported a position in RMD in Q4 2021 and has held it in 13 quarters since. The position peaked at $9K in Q4 2021. 167 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

CoreCap Advisors held 7 shares of ResMed worth $1.55K as of Q3 2026.
CoreCap Advisors bought 6 ResMed shares in Q3 2026, an estimated $1.31K.
ResMed made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #2573 holding.
CoreCap Advisors first reported a position in ResMed in Q4 2021 and has held it in 13 quarters since.
CoreCap Advisors's ResMed position peaked at $9K in Q4 2021.
167 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.